Results 51 to 60 of about 92,917 (279)

Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications. [PDF]

open access: yes, 2015
Fibroblast growth factors (FGFs) and their receptors (FGFRs) are transmembrane growth factor receptors with wide tissue distribution. FGF/FGFR signaling is involved in neoplastic behavior and also development, differentiation, growth, and survival.
Helsten, Teresa   +2 more
core   +2 more sources

Papillary Renal Cell Carcinoma [PDF]

open access: yesJournal of Diagnostic Medical Sonography, 1999
Papillary renal cell carcinoma comprises approximately 10% of all renal cell carcinomas. This subtype has a slower growth pattern, has less extensive involvement, and portends a better prognosis than do nonpapillary renal cell carcinomas. Papillary renal carcinomas tend to be avascular or hypovascular on ultrasound examination.
openaire   +1 more source

Papillary renal cell carcinoma with massive hematoma mimicking hemangioma

open access: yesRadiology Case Reports, 2019
It is extremely rare that papillary renal cell carcinoma has a massive hemorrhage. We report a case of papillary renal cell carcinoma with a massive hemorrhage which showed hemangioma-like imaging findings such as a globular discontinuous enhancement on ...
Yoshiki Hiraki, M.D.   +10 more
doaj   +1 more source

microRNA. Diagnostic Perspective [PDF]

open access: yes, 2015
Biomarkers are biological measures of a biological state. An ideal marker should be safe and easy to measure, cost efficient, modifiable with treatment, and consistent across gender and ethnic groups. To date, none of the available biomarkers satisfy all
FARUQ, MD OMAR, VECCHIONE, ANDREA
core   +2 more sources

Hereditary papillary renal cell carcinoma

open access: yesSeminars in Diagnostic Pathology
Hereditary papillary renal cell carcinoma (HPRCC) is an autosomal dominant syndrome characterized by the occurrence of bilateral and multifocal, classic type papillary renal cell carcinomas. In the recent decades, extensive molecular studies have narrowed the molecular underpinnings of this syndrome to missense mutations in tyrosine kinase domain of ...
Isa Mulingbayan Jacoba, Zhichun Lu
openaire   +2 more sources

The first case report of synchronous primary papillary type 2 renal cell carcinoma of kidney and transitional cell carcinoma of bladder

open access: yesUrology Case Reports, 2021
Synchronous presentation of Multiple Primary Malignant neoplasms in genitourinary system is not a common event. Absolute majority of reported cases are concurrent outbreak of clear cell type renal cell carcinoma in the kidney and transitional cell ...
Anahita Ansari Djafari   +3 more
doaj   +1 more source

Chromosome 9p deletion in clear cell renal cell carcinoma predicts recurrence and survival following surgery [PDF]

open access: yes, 2014
BACKGROUND: Wider clinical applications of 9p status in clear cell renal cell carcinoma (ccRCC) are limited owing to the lack of validation and consensus for interphase fluorescent in situ hybridisation (I-FISH) scoring technique.
Bondad, J.   +7 more
core   +4 more sources

Needle tract seeding in renal tumor biopsies: experience from a single institution

open access: yesDiagnostic Pathology, 2021
Background Percutaneous needle biopsy of renal masses has been increasingly utilized to aid the diagnosis and guide management. It is generally considered as a safe procedure.
Yan Zhou   +3 more
doaj   +1 more source

Prognostic relevance of the histological subtype of renal cell carcinoma [PDF]

open access: yes, 2008
OBJECTIVE: According to several studies, when the histological subtype of renal cell carcinoma is established it is possible to attribute a different life expectancy to each patient.
ANTUNES, Alberto A.   +5 more
core   +2 more sources

IL4I1⁺ Macrophages and TDO2⁺ Myofibroblasts Drive AhR‐Mediated Immunosuppression and Ferroptosis Resistance in Solid Predominant Lung Adenocarcinoma

open access: yesAdvanced Science, EarlyView.
Solid predominant lung adenocarcinoma exhibits an immune‐excluded, ferroptosis‐resistant niche enriched with IL4I1⁺ TAMs and TDO2⁺ myCAFs. Spatial and multi‐omics analyses reveal AhR‐driven crosstalk that promotes T cell exhaustion and therapy resistance. Blocking AhR with CH‐223191 restores ferroptosis sensitivity, and its combination with ferroptosis
Zhaoxuan Wang   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy